Precision System Science Co., Ltd. (7707.T)

JPY 191.0

(0.0%)

Revenue Summary of Precision System Science Co., Ltd.

  • Precision System Science Co., Ltd.'s latest annual revenue in 2023 was 3.97 Billion JPY , down -24.6% from previous year.
  • Precision System Science Co., Ltd.'s latest quarterly revenue in 2023 FY was 3.97 Billion JPY , down -24.6% from previous quarter.
  • Precision System Science Co., Ltd. reported a annual revenue of 5.27 Billion JPY in annual revenue 2022, down -29.0% from previous year.
  • Precision System Science Co., Ltd. reported a annual revenue of 7.43 Billion JPY in annual revenue 2021, down -20.05% from previous year.
  • Precision System Science Co., Ltd. reported a quarterly revenue of 929.1 Million JPY for 2023 Q3, down -1.15% from previous quarter.
  • Precision System Science Co., Ltd. reported a quarterly revenue of 939.95 Million JPY for 2023 Q2, down -12.33% from previous quarter.

Annual Revenue Chart of Precision System Science Co., Ltd. (2023 - 2007)

Created with Highcharts 11.1.0YearsRevenue200820102012201420162018202020222000000000 JPY4000000000 JPY6000000000 JPY8000000000 JPY10000000000 JPY

Historical Annual Revenue of Precision System Science Co., Ltd. (2023 - 2007)

Year Revenue Revenue Growth
2023 3.97 Billion JPY -24.6%
2022 5.27 Billion JPY -29.0%
2021 7.43 Billion JPY -20.05%
2020 9.29 Billion JPY 83.51%
2019 5.06 Billion JPY 15.65%
2018 4.38 Billion JPY 20.33%
2017 3.64 Billion JPY -5.35%
2016 3.84 Billion JPY -13.71%
2015 4.45 Billion JPY -13.32%
2014 5.14 Billion JPY 31.15%
2013 3.92 Billion JPY -2.67%
2012 4.02 Billion JPY 14.46%
2011 3.52 Billion JPY 12.01%
2010 3.14 Billion JPY -44.26%
2009 5.63 Billion JPY 48.27%
2008 3.8 Billion JPY 11.91%
2007 3.39 Billion JPY 0.0%

Peer Revenue Comparison of Precision System Science Co., Ltd.

Name Revenue Revenue Difference
Shin Nippon Biomedical Laboratories, Ltd. 26.45 Billion JPY 84.953%
DNA Chip Research Inc. 490.46 Million JPY -711.47%
Cosmo Bio Company,Limited 9.34 Billion JPY 57.388%
H.U. Group Holdings, Inc. 236.95 Billion JPY 98.32%
FALCO HOLDINGS Co., Ltd. 43 Billion JPY 90.746%
BML, Inc. 137.96 Billion JPY 97.115%
Human Metabolome Technologies, Inc. 1.34 Billion JPY -195.76%